Amendments for: 172-2019-2020-Q2-931269
Current (Dec 13, 2019)
Agreement: Development of the GoalNav Platform, a Clinical Trial System for Patient-Centric Outcomes Measurement (931269). Jul 8, 2019 - Mar 18, 2020
Description:
Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.
Expected Results:The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Organization: National Research Council CanadaRecipient: DGI Clinical Inc. (For-profit organization)
Location: Halifax, Nova Scotia, CA B3J 2E3
Type: Contribution
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 78 days. The total amended value is 56,475 dollars.
Federal Riding Name: Halifax (12005)Program Name: Industrial Research Assistance Program – Contributions to Firms
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.NAICS Code: 541710
Amendment 01 (Dec 13, 2019)
Organization: National Research Council Canada
Recipient: -
Type: -
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 78 days. The total amended value is 56,475 dollars.
Amendment 00
Agreement: Development of the GoalNav Platform, a Clinical Trial System for Patient-Centric Outcomes Measurement (931269). Jul 8, 2019 - Dec 31, 2019
Description:
Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.
Expected Results:The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Organization: National Research Council CanadaRecipient: DGI Clinical Inc. (For-profit organization)
Location: Halifax, Nova Scotia, CA B3J 2E3
Type: Contribution
Federal Riding Name: Halifax (12005)
Program Name: Industrial Research Assistance Program – Contributions to Firms
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.NAICS Code: 541710